Dismissed Too Soon: A Practical Framework for Challenging Premature CJD Exclusions

The phrase arrives with the quiet authority of clinical confidence: "It's probably not CJD." For families already frightened by the rapid deterioration they are witnessing, those words can feel like a reprieve. In many cases, they are correct — most presentations of rapidly progressive cognitive decline are not caused by prion disease. But in a meaningful subset of cases, that reassurance is premature. It is offered not because CJD has been adequately ruled out, but because the physician has made an informal probability judgment without the testing or specialist input required to support it.

Knowing the difference — and knowing what to do when you suspect premature dismissal — is essential knowledge for any family navigating a possible CJD diagnosis.

Why Premature Dismissal Happens

Physicians are not dismissing CJD out of negligence or indifference. They are responding to real statistical and logistical pressures. CJD is genuinely rare, affecting roughly one in one million people annually in the United States. The overwhelming majority of patients presenting with memory loss, personality change, or movement disorders have other diagnoses. A neurologist who reflexively ordered prion disease workups on every patient with cognitive decline would be practicing poor medicine.

The problem arises when probability reasoning substitutes for evidence-based exclusion. Saying "this probably isn't CJD" is a probabilistic statement. Saying "we have tested for CJD and the results are not consistent with that diagnosis" is an evidence-based statement. The two are not equivalent, and families deserve to know which category their physician's conclusion falls into.

Additional factors compound the problem. CJD is not routinely included in the standard differential diagnosis training that most neurologists receive. Its presentations are heterogeneous — some patients present with dementia, others with cerebellar ataxia, others with psychiatric symptoms that initially route them to mental health providers rather than neurology. A clinician who has never personally managed a CJD case may not recognize atypical presentations at all.

Step One: Establish What Testing Has Actually Been Done

Before challenging a physician's conclusion, families need to understand the evidentiary basis for it. This requires asking direct, specific questions rather than accepting general reassurances.

The key questions are:

• Has a brain MRI been performed using diffusion-weighted imaging (DWI) sequences? Standard MRI protocols may not be sensitive to the cortical ribboning pattern characteristic of CJD. DWI-specific protocols are necessary.
• Has cerebrospinal fluid (CSF) testing been ordered, specifically including real-time quaking-induced conversion (RT-QuIC) assay? RT-QuIC has a sensitivity exceeding 90 percent for sporadic CJD and is the current gold standard for CSF-based diagnosis.
• Has genetic testing been performed to evaluate for mutations in the PRNP gene, which would indicate familial CJD?
• Has an electroencephalogram (EEG) been performed to evaluate for periodic sharp wave complexes, a finding associated with certain CJD subtypes?

If the answer to any of these questions is no, the physician's conclusion that CJD is unlikely is based on incomplete information. That is not an accusation — it is a factual observation that families can and should raise directly.

Step Two: Document Everything in Writing

Oral conversations with physicians are difficult to act on later. When a family has concerns about premature dismissal, creating a written record is essential.

After any appointment where CJD is discussed and dismissed, send a follow-up message through the patient portal or in writing to the physician's office. The message should be factual and non-confrontational. It should state the specific symptoms that prompted concern, ask which diagnostic tests have been ordered to evaluate for CJD, and note any family history of neurological disease that might be relevant to genetic CJD risk.

This documentation serves multiple purposes. It creates a timestamped record of the family's concerns. It places the physician in the position of either ordering additional testing or providing a written explanation of why those tests are not warranted. And it establishes a paper trail that will be useful if the family subsequently seeks a second opinion or escalates to a specialist.

Step Three: Request a Formal Neurology Referral

If a patient has been evaluated by a primary care physician and CJD concerns have been dismissed, the appropriate next step is a formal referral to neurology — specifically, to a neurologist with subspecialty training or experience in prion diseases or rapidly progressive dementias.

General neurologists vary widely in their familiarity with CJD. Families should ask specifically whether the neurologist has managed prion disease cases before, and whether they have a relationship with an academic center that has CJD expertise. If the referring physician is reluctant to make that referral, families have the right to request it directly and to seek a second opinion independently.

In the Newark area, academic medical centers with active neurology departments and research programs in neurodegeneration offer access to clinicians whose clinical experience with rare neurological diseases significantly exceeds that of community-based practitioners. Families should not assume that geographic inconvenience justifies accepting a lower standard of diagnostic care.

Step Four: Know When to Escalate

There are specific circumstances that should prompt immediate escalation regardless of a physician's expressed confidence that CJD is unlikely:

• Cognitive or functional decline progressing over weeks rather than months
• The presence of myoclonus (involuntary muscle jerking)
• Visual disturbances combined with cognitive change
• Any family history of early-onset dementia or prion disease
• Prior history of neurosurgical procedures, dural grafts, or growth hormone treatment from cadaveric sources (risk factors for iatrogenic CJD)

In these circumstances, waiting for a physician to become more concerned is not a reasonable strategy. Families should request an urgent neurology consultation and, if that request is declined, consider presenting to an emergency department or seeking direct evaluation at an academic medical center.

The Emotional Cost of Advocacy

It is worth acknowledging that advocating assertively in a medical context is genuinely difficult. Patients and families are frightened, exhausted, and operating in an environment where medical authority carries enormous social weight. Pushing back against a physician's reassurance can feel presumptuous or even ungrateful.

But the stakes in a possible CJD case are too high for deference to override evidence. The disease progresses rapidly. Diagnostic windows close. Families who later learn that months were lost to premature reassurance carry a particular kind of grief. The frameworks described in this article are not about confrontation — they are about ensuring that clinical conclusions are supported by the evidence required to reach them.

You are not required to accept a probabilistic dismissal as a final answer. You are entitled to ask what testing has been done, to request the testing that has not been done, and to seek subspecialty consultation when your concerns are not being adequately addressed. That is not difficult behavior. It is appropriate, necessary, and potentially life-altering advocacy.